Neuroblastoma stage 4S: Tumor regression rate and risk factors of progressive disease.
Tas ML, Nagtegaal M, Kraal KCJM, Tytgat GAM, Abeling NGGM, Koster J, Pluijm SMF, Zwaan CM, de Keizer B, Molenaar JJ, van Noesel MM.
Tas ML, et al. Among authors: nagtegaal m.
Pediatr Blood Cancer. 2020 Apr;67(4):e28061. doi: 10.1002/pbc.28061. Epub 2019 Nov 17.
Pediatr Blood Cancer. 2020.
PMID: 31736229